Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

American Healthcare REIT (AHR) Gains from Sales and Divestitures (2024 - 2025)

American Healthcare REIT (AHR) has disclosed Gains from Sales and Divestitures for 2 consecutive years, with $158889.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Gains from Sales and Divestitures rose 194.18% year-over-year to $158889.0, compared with a TTM value of $158889.0 through Dec 2025, up 194.18%, and an annual FY2025 reading of $158889.0, up 194.18% over the prior year.
  • Gains from Sales and Divestitures was $158889.0 for Q4 2025 at American Healthcare REIT, roughly flat from $158889.0 in the prior quarter.
  • Across five years, Gains from Sales and Divestitures topped out at $158889.0 in Q3 2025 and bottomed at $54010.0 in Q4 2024.